Magnesium attenuates isoproterenol-induced acute cardiac dysfunction and β-adrenergic desensitization

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 292, Issue 3, 2007, Pages

  Jin, Yin Tie ^a   Hasebe, Naoyuki ^a   Matsusaka, Tomoyuki ^a   Natori, Shunsuke ^a   Ohta, Takafumi ^a   Tsuji, Shiro ^a   Kikuchi, Kenjiro ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Calcium overload; Dog, left ventricular; Free radical; Tau

Indexed keywords

BETA ADRENERGIC RECEPTOR; CALCIUM ION; CATECHOLAMINE; FREE RADICAL; ISOPRENALINE; LIPID PEROXIDE; MAGNESIUM;

ACUTE HEART FAILURE; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DESENSITIZATION; DIASTOLIC DYSFUNCTION; DISEASE MARKER; DOG; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; DRUG RESPONSE; FEMALE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE CONTRACTION; HEART MUSCLE INJURY; HEART PROTECTION; HEART VENTRICLE OVERLOAD; LIPID BLOOD LEVEL; LOW DRUG DOSE; MALE; NONHUMAN; PRIORITY JOURNAL; SEROLOGY;

ANIMALS; AORTA, THORACIC; BLOOD PRESSURE; DOGS; FEMALE; HEART DISEASES; ISOPROTERENOL; MAGNESIUM; MALE; RECEPTORS, ADRENERGIC, BETA; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33847694326     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00985.2006     Document Type: Article

References (47)

1. Allard MF, Flint JD, English JC, Henning SL, Salamanca MC, Kamimura CT, English DR. Calcium overload during reperfusion is accelerated in isolated hypertrophied rat hearts. J Mol Cell Cardiol 26: 1551-1563, 1994.
2. Bashir Y, Sneddon JF, Staunton HA, Haywood GA, Simpson IA, McKenna WJ, Camm AJ. Effects of long-term oral magnesium chloride replacement in congestive heart failure secondary to coronary artery disease. Am J Cardiol 72: 1156-1162, 1993.
3. Bowling N, Wyss VL, Gengo PJ, Utterback B, Kauffman RF, Hayes JS. Cardiac inotropic responses to calcium and forskolin are not altered by prolonged isoproterenol infusion. Eur J Pharmacol 187: 155-164, 1990.
4. Brembilla Perrot B, Terrier de la Chaise A, le Van D, Beurrier D. Effect of isoproterenol on serum potassium and magnesium. Eur Heart J 14: 677-81, 1993.
5. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB. Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts. N Engl J Med 307: 205-211, 1982.
6. Chatelain P, Laruel A, Beaufort P, Meysmans L, Clinet M. Prevention of calcium overload and down-regulation of calcium channels in rat heart by SR 33557, a novel calcium entry blocker. Cardioscience 3: 117-123, 1992.
7. CIBISII investigators and committees. The cardiac insufficiency bisoprolol study II (CIBIS-II); a randomised trial. Lancet 353: 9-13, 1999.
8. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311: 819-823, 1984.
9. Feldman RD. Beta-adrenergic desensitization reduces the sensitivity of adenylate cyclase for magnesium in permeabilized lymphocytes. Mol Pharmacol 35: 304-310, 1989.
10. Ganguly PK. Impaired inotropic responses to adrenergic stimulation following aortic constriction: role of oxidation product of catecholamines. Angiology 42: 133-139, 1991.
11. Garcia LA, Dejong SC, Martin SM, Smith RS, Buettner GR, Kerber RE. Magnesium reduces free radicals in an in vivo coronary occlusion-reperfusion model. J Am Coll Cardiol 32: 536-539, 1998.
12. Gilman AG. G proteins: transducers of receptor-generated signals. Annu Rev Biochem 56: 615-649, 1987.
13. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 339: 489-497, 1998.
14. Grimm D, Elsner D, Schunkert H, Pfeifer M, Griese D, Bruckschlegel G, Muders F, Riegger GA, Kromer EP. Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system. Cardiovasc Res 37: 91-100. 1998.
15. Guideri G. Catecholamine modulation of magnesium plasma levels in the rat. Arch Int Pharmacodyn Ther 320: 103-114, 1992.
16. Hasebe N, Shen YT, Kiuchi K, Hittinger L, Bishop SP, Vatner SF. Enhanced postischemic dysfunction selective to subendocardium in conscious dogs with LV hypertrophy. Am J Physiol Heart Circ Physiol 266: H702-H713, 1994.
17. Hasebe N, Shen YT, Vatner SF. Inhibition of endothelium-derived relaxing factor enhances myocardial stunning in conscious dogs. Circulation 88: 2862-2871, 1993.
18. Hertel C, Perkins JP. Receptor-specific mechanisms of desensitization of β-adrenergic receptor unction. Mol Cell Endocrinol 37: 245-256, 1984.
19. 2+ overload. Circ Res 75: 324-334, 1994.
20. 2+ transient in rat myocytes during beta-adrenergic stimulation. J Physiol 505: 385-402, 1997.
21. Iseri LT, French JH. Magnesium: nature's physiologic calcium blocker. Am Heart J 108: 188-193, 1984.
22. 2+ and enhancing its extent of activation by guanine nucleotides. Proc Natl Acad Sci USA 79: 5179-5183, 1982.
23. 2+ in the rat by δ1 and β2-adrenergic receptor stimulation. Circ Res 77: 973-983, 1995.
24. Kudej RK, Iwase M, Uechi M, Vatner DE, Oka N, Ishikawa Y, Shannon RP, Bishop SP, Vatner SF. Effects of chronic β-adrenergic receptor stimulation in mice. J Mol Cell Cardiol 29: 2735-2746, 1997.
25. 2+ ATPase gene expression in congestive heart failure: effect of chronic norepinephrine infusion. J Mol Cell Cardiol 30: 175-185, 1998.
26. Matsusaka T, Hasebe N, Jin YT, Kawabe J, Kikuchi K. Magnesium reduces myocardial infarct size via enhancement of adenosine mechanism in rabbits. Cardiovasc Res 54: 568-575, 2002.
27. MERITHF Study Group. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure. Lancet 353: 2001-2007, 1999.
28. 2+, adenine nucleotide, and calmodulin. J Biol Chem 262: 3065-3073, 1987.
29. Natori S, Hasebe N, Jin YT, Matsusaka T, Ido A, Matsuhashi H, Ihara T, Kikuchi K. Inhaled nitric oxide modifies left ventricular diastolic stress in the presence of vasoactive agents in heart failure. Am J Respir Crit Care Med 167: 895-901, 2003.
30. Nishimura H, Matsubara T, Ikoma Y, Nakayama S, Sakamoto N. Effects of prolonged application of isoprenaline on intracellular free magnesium concentration in isolated heart of rat. Br J Pharmacol 109: 443-448, 1993.
31. Ohta T, Hasebe N, Tsuji S, Izawa K, Jin YT, Kido S, Natori S, Sato M, Kikuchi K. Unequal effects of renin-angiotensin system inhibitors in acute cardiac dysfunction induced by isoproterenol. Am J Physiol Heart Circ Physiol 287: H2914-H2921, 2004.
32. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH. US Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334: 1349-1355, 1996.
33. Peters SL, Pfaffendorf M, van Zwieten PA. The influence of oxidative stress on various inotropic responses in isolated rat left atria. Naunyn Schmiedebergs Arch Pharmacol 355: 390-397, 1997.
34. Powers FM, Pifarre R, Thomas JX Jr. Ventricular dysfunction in norepinephrine-induced cardiomyopathy. Circ Shock 43: 122-129, 1994.
35. Rathore N, John S, Kale M, Bhatnagar D. Lipid peroxidation and antioxidant enzymes in isoproterenol induced oxidative stress in rat tissues. Pharmacol Res 38: 297-303, 1998.
36. Shizukuda Y, Buttrick PM, Geenen DL, Borczuk AC, Kitsis RN, Sonnenblick EH. β-Adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy. Am J Physiol Heart Circ Physiol 275: H961-H968, 1998.
37. Singal PK, Kapur N, Dhillon KS, Beamish RE, Dhalla NS. Role of free radicals in catecholamine-induced cardiomyopathy. Can J Pharmacol 60: 1390-1397, 1982.
38. Sommers KE, Ohkado A, Simplaceanu E, Koretsky AP, Ho C, del Nido PJ. The role of magnesium in postischemic cardiac dysfunction. Surgery 112: 159-165, 1992.
39. Su YF, Harden TK, Perkins JP. Catecholamine-specific desensitization of adenylate cyclase. Evidence for a multistep process. J Biol Chem 255: 7410-7419, 1980.
40. 3H]batrachotoxinin benzoate binding sites on rat cardiac myocytes. J Biol Chem 266: 10300-10304, 1991.
41. 2+ transients of rat ventricular myocytes. Am J Physiol Heart Circ Physiol 270: H907-H914, 1996.
42. Weiss JL, Frederiksen JW, Weisfeldt ML. Hemodynamic determinants of the time-course of fall in canine left ventricular pressure. J Clin Invest 58: 751-760, 1976.
43. Widman L, Wester PO, Stegmayr BK, Wirell M. The dose-dependent reduction in blood pressure through administration of magnesium. A double blind placebo controlled cross-over study. Am J Hypertens 6: 41-45, 1993.
44. Woods KL. Possible pharmacological actions of magnesium in acute myocardial infarction. Br J Clin Pharmacol 32: 3-10, 1991.
45. 2+, and adenine nucleotides under normal and simulated ischemic conditions. Circ Res 79: 1100-1109, 1996.
46. 2+ in frog ventricular cells. Pflügers Arch 431: 305-317, 1996.
47. 2+ efflux from the isolated perfused rabbit heart is mediated by two states of the β1-adrenergic receptor. Naunyn Schmiedebergs Arch Pharmacol 366: 431-9, 2002.